Olaplex Holdings reported its first-quarter 2026 results Monday morning, but in the form of a press release without an attached conference call or updated guidance — a deliberate signal from a company that knows the next thing investors actually care about is the closing date on its Henkel takeover.

The print itself: net sales grew 2.5% year-over-year to $99.4 million, per StockTitan's results summary. But beneath the top-line growth was the kind of channel mix that helps explain why Olaplex took Henkel's offer in March:

  • Professional channel (salons and licensed stylists): $38.8 million, up 12.3% year-over-year
  • Direct-to-Consumer (Olaplex.com): $27.2 million, up 13.8%
  • Specialty Retail (Sephora, Ulta, Sally Beauty et al.): $33.4 million, down 13.3%

The bottom line swung to a $5.3 million net loss from a $0.5 million net income in the prior-year period. Adjusted EBITDA margin compressed from 26.5% to 19.1%. There was no Q&A, no analyst call, and no fresh guidance, because, as the Manila Times release noted, the pending acquisition by Henkel made forward-looking commentary functionally pointless.

The Acquisition Math, Now That We Have Q1

The Henkel deal — announced March 26 and covered at the time by Retail Dive and CNBC — values Olaplex at $2.06 per share, or roughly $1.4 billion. That was a 55% premium to the March 25 close.

Running the back-of-envelope on Q1: annualizing Q1 net sales at $99.4 million gives a ~$398 million run-rate. Henkel said in its press release that Olaplex generated approximately €370 million ($395 million at current rates) in 2025 sales. So Q1 essentially confirmed the run-rate Henkel underwrote.

At a $1.4 billion enterprise value against a ~$400 million revenue base, Henkel is paying roughly 3.5x sales — high enough to make the deal real, low enough to look reasonable against a company that, per WWD's reporting, had lost 95% of its market cap since its 2021 IPO. The structural problem Henkel inherits is the specialty retail melt — and Q1's negative 13.3% in that channel suggests the trough may not yet be in.

What Specialty Retail Says About Prestige Beauty

This is the line worth sitting with for retail readers. Specialty Retail is Olaplex's shelf presence at Sephora, Ulta, Sally, and a long tail of independents. A 13.3% YoY decline in that channel — while professional and DTC both grew low-double-digits — is a clear demand-routing story. Stylists are still buying. Loyalty customers are still buying direct. The non-loyal, prestige-shelf walk-in shopper is the one rotating out.

That mirrors what Coty just reported on its earnings call last week (Endcap covered this Saturday). It mirrors what Estée Lauder told analysts about its department-store partner exits. And it mirrors the central thesis of eMarketer's prestige-beauty downgrade: the prestige-shelf walk-in trip is bleeding to professional (where you trust the recommender) or to direct (where the brand owns the relationship). The middle is hollowing.

Henkel's strategic rationale, as CEO Carsten Knobel framed it in March, is to plug Olaplex into Henkel's massive professional-distribution backbone (Schwarzkopf Professional, Indola, Joico) where it can lean into the channels that are working. That's a plausible read on the deal. It's also an admission that the specialty retail leg can't be saved as a standalone strategy.

What to Watch Through Close

The deal is expected to close in the second half of 2026 — per Advent International's deal notice — with Olaplex delisting from Nasdaq at close. Three things worth tracking:

  1. Will Henkel keep Olaplex's specialty retail footprint, slim it, or zero it out? Henkel's professional-first strategy could rationalize the Sephora/Ulta presence dramatically. The fate of shelf placement is what every prestige-beauty retail buyer should be asking their Olaplex rep right now.
  2. Antitrust review timing. With Henkel's Schwarzkopf already a top-5 global pro-hair player, a $1.4 billion bolt-on triggers HSR review and likely EU CMA scrutiny. Closing "second half" implies somewhere between September and December.
  3. The next prestige-beauty domino. Coty's stock has been the beauty-sector punching bag. Several analysts have begun openly speculating Coty's next strategic move could be a take-private or a divisional split. Henkel's willingness to pay 3.5x sales for an asset everyone calls structurally challenged just put a floor under those conversations.

For now, Olaplex's last-as-a-public-company quarter looks exactly like what it was: a brand in the middle of its sale process, churning out a quiet print and turning the lights down on its public-market chapter. The interesting question is what Henkel does with it next.